Emr 28 21 Dec 51 Bond Cash Per Share
| 291011BS2 | 63.68 3.54 5.89% |
EMR 28 21 DEC 51 fundamentals help investors to digest information that contributes to 291011BS2's financial success or failures. It also enables traders to predict the movement of 291011BS2 Bond. The fundamental analysis module provides a way to measure 291011BS2's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 291011BS2 bond.
291011BS2 |
EMR 28 21 DEC 51 Corporate Bond Cash Per Share Analysis
291011BS2's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
In accordance with the recently published financial statements, EMR 28 21 DEC 51 has a Cash Per Share of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Cash Per Share (which currently averages 0.0) industry. This indicator is about the same for all United States bonds average (which is currently at 0.0).
291011BS2 Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 291011BS2's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the bonds which would be a good addition to a portfolio. Peer analysis of 291011BS2 could also be used in its relative valuation, which is a method of valuing 291011BS2 by comparing valuation metrics of similar companies.EMR 28 cannot be rated in Cash Per Share category at this point.
About 291011BS2 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EMR 28 21 DEC 51's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 291011BS2 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EMR 28 21 DEC 51 based on its fundamental data. In general, a quantitative approach, as applied to this corporate bond, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in 291011BS2 Bond
291011BS2 financial ratios help investors to determine whether 291011BS2 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 291011BS2 with respect to the benefits of owning 291011BS2 security.